These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21196926)

  • 21. Multiregional sampling reveals a homogenous distribution of Ki-67 proliferation rate in pituitary adenomas.
    Wolfsberger S; Kitz K; Wunderer J; Czech T; Boecher-Schwarz HG; Hainfellner JA; Knosp E
    Acta Neurochir (Wien); 2004 Dec; 146(12):1323-7; discussion 1327-8. PubMed ID: 15480830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
    Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
    Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Ki-67 in acromegalic patients with hyperprolactinemia: retrospective analysis in 61 Chinese Patients.
    Huan C; Cui G; Lu C; Qu X; Han T
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):719-23. PubMed ID: 25796164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
    Hellberg D; Tot T; Stendahl U
    Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
    Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis in pituitary adenomas.
    Yamada S; Takada K
    Microsc Res Tech; 2003 Feb; 60(2):236-43. PubMed ID: 12539178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
    Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
    Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic therapy and curative effect in pituitary adenoma patients complicated by acromegalic cardiomyopathy.
    Zhou H; Zha Z; Li X; Chen X; Wang J; Su Z
    Neurosurg Rev; 2018 Jul; 41(3):869-875. PubMed ID: 29238923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexistence of ectopic pituitary adenoma and empty sella in a patient with acromegaly : a case report and review of literature.
    Hong JF; Ding XH; Wang SS
    Neurol India; 2012; 60(3):304-6. PubMed ID: 22824688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transphenoidal surgery in acromegalic patients: anatomical considerations and potential pitfalls.
    Carrabba G; Locatelli M; Mattei L; Guastella C; Mantovani G; Rampini P; Gaini SM
    Acta Neurochir (Wien); 2013 Jan; 155(1):125-30; discussion 130. PubMed ID: 23180167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery.
    Jagannathan J; Sheehan JP; Pouratian N; Laws ER; Steiner L; Vance ML
    Neurosurgery; 2008 Jun; 62(6):1262-9; discussion 1269-70. PubMed ID: 18824992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly.
    Gradiser M; Matovinovic M; Vrkljan M
    Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic correlates of giant pituitary adenomas.
    Chacko G; Chacko AG; Lombardero M; Mani S; Seshadri MS; Kovacs K; Scheithauer BW
    J Clin Neurosci; 2009 May; 16(5):660-5. PubMed ID: 19285407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolution of Chiari malformation after treatment of acromegaly. Case illustration.
    Ammerman JM; Goel R; Polin RS
    J Neurosurg; 2006 Jun; 104(6):980. PubMed ID: 16776347
    [No Abstract]   [Full Text] [Related]  

  • 37. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma.
    Kondo Y; Arii S; Furutani M; Isigami S; Mori A; Onodera H; Chiba T; Imamura M
    Cancer; 2000 Apr; 88(8):1820-7. PubMed ID: 10760758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cavernous sinus invasion and effect of immunohistochemical features on remission in growth hormone secreting pituitary adenomas.
    Yilmaz M; Vural E; Koc K; Ceylan S
    Turk Neurosurg; 2015; 25(3):380-8. PubMed ID: 26037177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas.
    Shirian FI; Ghorbani M; Khamseh ME; Imani M; Panahi M; Alimohammadi A; Nourbakhsh M; Salimi V; Tavakoli-Yaraki M
    BMC Endocr Disord; 2021 Mar; 21(1):50. PubMed ID: 33736633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
    Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.